Clinical Trial of tipifarnib in HRAS Positive Advanced Squamous Cell Cancer

A clinical trial of an investigational new drug, tipifarnib, is currently enrolling adults WITH hras positive ADvanced squamous cell cancer

WHO: Adults with HRAS Positive Advanced Squamous Cell Cancer

WHAT:  A clinical trial for an investigational new drug, tipifarnib

TRAVEL EXPENSES:  Qualified participants in this clinical trial may be reimbursed for related travel, as applicable


Who is the person interested in participating in this clinical trial/HRAS mutation testing? *
Has the person above been diagnosed with squamous cell cancer in any of these areas? *
Has a doctor told the person above that his/her tumor is locally advanced or metastasized (spread to other parts of the body)? *
Has the person above previously undergone genetic testing? *
Is this person's age at least 18 years old? *
Date of birth of the person above *
Date of birth of the person above
Name *
Phone Number *
Phone Number
Enter the US Postal Zip Code for your address
Best time to contact you
Agreement to Terms of Use, Privacy Policy and GDPR *
Yes, please contact me *

Thank you for your submission. If you qualify, a nurse case manager will call or email you.